BC Week In Review | Jan 4, 2010
Clinical News

E regulatory update

AdvanDx received 510(k) clearance from FDA for a 90-minute protocol for its E. coli/P. aeruginosa PNA FISH and EK/P. aeruginosa PNA FISH nucleic acid hybridization assays for use with blood cultures to detect Escherichia coli...
BC Week In Review | May 11, 2009
Clinical News

EK/P regulatory update

FDA granted 510(k) clearance for AdvanDx's EK/P. aeruginosa PNA FISH, a nucleic acid hybridization assay for identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa bacterial infections from positive blood cultures. AdvanDx Inc. , Woburn, Mass.  ...
Items per page:
1 - 2 of 2